ABUS vs HON
Arbutus Biopharma Corp (ABUS) versus Honeywell International Inc (HON) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Not investment advice. Open the ABUS and HON stock pages for the full models.
Not investment advice.